GE HealthCare Technologies Inc. (GEHC)
GE HealthCare Technologies Inc. (GEHC) carries a ŷRobot AI score of 42 out of 100. The model's fair value estimate is $76.72, 6.3% below the last close of $81.84. The chart signal reads Hold.
| Metric | GEHC |
|---|---|
| AI score | 42 / 100 |
| Chart signal | Hold |
| Fair value estimate | $76.72 |
| Upside to fair value | -6.3% |
| Previous close | $81.84 |
| P/E | 16.34 |
| Price / sales | 1.61 |
| Market cap | $37.35B |
| EPS | 4.64 |
| Revenue growth | 3.6% |
| 1-year price change | -5.5% |
How these numbers are built: the AI score, the fair value model, and the chart signal.
Other Healthcare stocks: Eli Lilly and Company, Johnson & Johnson, AbbVie Inc, Merck & Company Inc, UnitedHealth Group Incorporated, Novartis AG ADR.
Questions about GEHC
Is GEHC overvalued or undervalued right now?
As of Oct 30, 2026, ŷRobot's fair-value model estimates GE HealthCare Technologies Inc. (GEHC) at $76.72 against a last close of $81.84, implying 6.3% downside to the model's estimate.
Is GEHC's chart signal bullish or bearish?
The chart-signal model classifies GEHC as Neutral as of Nov 13, 2026, with a signal score of 0.02 on a -1 to 1 scale.
What is GEHC's ŷRobot AI score?
GEHC scores 42 out of 100 on ŷRobot's AI composite, which measures how strongly the fair-value and chart models agree, as of Nov 13, 2026.
Is GEHC stock expensive on P/E and P/S?
GEHC trades at 16.3 times earnings and 1.6 times sales as of Nov 13, 2026.
What does GEHC's seasonal forecast show?
ŷRobot's seasonal forecast curve for GEHC reads -2.1% at 30 days, -4.2% at 90 days, and -5.5% at one year as of Nov 13, 2026. Seasonal tendencies are historical patterns, not predictions.
How fast is GEHC growing?
GE HealthCare Technologies Inc.'s revenue growth is +3.6% and free-cash-flow growth is -1.3% on the latest reported figures.
GEHC chart and technical read · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.